← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
37
Oct 2026
Equity Holdings
₹5,890.27 Cr
Equity only, excl. debt & cash
AAUM
₹5,369.64 Cr
Jul-Sep 2026 · Direct + Regular
Top 5 Weight
33.7%
Moderate
Top 10 Weight
53.1%
Moderate
Changes
38
3 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
64.1% of portfolio
Launch Date
01 Jan 1993
10+ year track record

AAUM (Average Assets Under Management) of ₹5,369.64 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND made 3 new additions and exited 1 stock this month. The biggest new buy was Paras Healthcare Ltd. (Healthcare Services) at 2.49% weight. Rainbow Childrens Medicare Limited was the biggest exit (Healthcare Services), which was held at 0.67%. Among existing holdings, Max Healthcare Institute Limited saw the biggest increase — now at 4.96% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 10.55%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.1%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 64.9% 65.9% ▲ +1.0%
Healthcare Services 27.6% 25.6% ▼ -2.0%
Chemicals & Petrochemicals 2.3% 2.2% ▼ -0.2%
Healthcare Equipment & Supplies 1.9% 1.8% ▼ -0.1%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 65.9% 64.1% ▼ -1.8%
Healthcare Services 25.6% 29.4% ▲ +3.7%
Chemicals & Petrochemicals 2.2% 2.0% ▼ -0.2%
Healthcare Equipment & Supplies 1.8% 1.5% ▼ -0.3%
🟢
Biggest New Buy
Paras Healthcare Ltd.
2.49% weight · Healthcare Services
🔴
Biggest Exit
Rainbow Childrens Medicare Limited
0.67% was held · Healthcare Services
↑
Biggest Add
Max Healthcare Institute Limited
+1.16% · now 4.96%
↓
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.59% · now 10.55%
🤝 Other funds also bought this month
Zydus Lifesciences Limited 38 funds
Zydus Lifesciences Limited
quant Aggressive Hybrid Fund-Growth Option-Direct Plan
quant Healthcare Fund - Growth Option - Direct Plan
quant Consumption Fund - Growth Option - Direct Plan + more
Paras Healthcare Ltd. 19 funds
Paras Healthcare Ltd.
ITI ELSS Tax Saver Fund - Direct Plan - Growth Option
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
Kotak Healthcare Fund - Direct Plan - Growth Option + more
Manipal Health Enterprises Ltd 4 funds
Manipal Health Enterprises Ltd
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth
Bandhan Mid Cap Fund
Bandhan BSE Healthcare Index Fund Direct Plan - Growth + more
👋 Other funds also exited
Rainbow Childrens Medicare Limited 9 funds
Rainbow Childrens Medicare Limited
WhiteOak Capital Pharma and Healthcare Fund
Kotak Healthcare Fund - Direct Plan - Growth Option
ICICI Prudential Quality Fund - Direct Plan - Growth + more

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
🟢 3 New Entries 🔴 1 Exit ↑ 7 Increased ↓ 27 Decreased
#StockSectorWeight (Oct 2026)
1
Paras Healthcare Ltd.
₹151.30 Cr
Healthcare Services 2.49%
2
Manipal Health Enterprises Ltd
₹60.22 Cr
Healthcare Services 0.99%
3
Zydus Lifesciences Limited
₹28.58 Cr
Pharmaceuticals & Biotechnology 0.47%
#StockSectorLast Weight (Sep 2026)
1
Rainbow Childrens Medicare Limited
₹39.43 Cr
Healthcare Services 0.67%
#StockSectorSep 2026Oct 2026Change
1
Max Healthcare Institute Limited
₹301.05 Cr
Healthcare Services 3.80% 4.96% +1.16%
2
Laurus Labs Limited
₹288.66 Cr
Pharmaceuticals & Biotechnology 4.05% 4.76% +0.71%
3
Divi's Laboratories Limited
₹508.56 Cr
Pharmaceuticals & Biotechnology 7.91% 8.38% +0.47%
4
Apollo Hospitals Enterprise Limited
₹295.17 Cr
Healthcare Services 4.45% 4.87% +0.42%
5
Krishna Institute Of Medical Sciences Limited
₹112.29 Cr
Healthcare Services 1.69% 1.85% +0.16%
6
Gland Pharma Limited
₹185.75 Cr
Pharmaceuticals & Biotechnology 2.96% 3.06% +0.10%
7
Syngene International Limited
₹72.49 Cr
Healthcare Services 1.12% 1.19% +0.07%
#StockSectorSep 2026Oct 2026Change
1
Sun Pharmaceutical Industries Limited
₹639.97 Cr
Pharmaceuticals & Biotechnology 11.14% 10.55% -0.59%
2
Mankind Pharma Limited
₹74.78 Cr
Pharmaceuticals & Biotechnology 1.71% 1.23% -0.48%
3
Sudeep Pharma Limited
₹145.29 Cr
Pharmaceuticals & Biotechnology 2.79% 2.39% -0.40%
4
Healthcare Global Enterprises Limited
₹81.98 Cr
Healthcare Services 1.70% 1.35% -0.35%
5
Aurobindo Pharma Limited
₹188.32 Cr
Pharmaceuticals & Biotechnology 3.42% 3.10% -0.32%
6
Torrent Pharmaceuticals Limited
₹249.12 Cr
Pharmaceuticals & Biotechnology 4.42% 4.11% -0.31%
7
Poly Medicure Limited
₹92.77 Cr
Healthcare Equipment & Supplies 1.82% 1.53% -0.29%
8
Concord Biotech Limited
₹119.58 Cr
Pharmaceuticals & Biotechnology 2.25% 1.97% -0.28%
9
Innova Captab Limited
₹85.44 Cr
Pharmaceuticals & Biotechnology 1.65% 1.41% -0.24%
10
Ajanta Pharma Limited
₹94.74 Cr
Pharmaceuticals & Biotechnology 1.79% 1.56% -0.23%

What Stocks Does This Fund Hold?

37 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹639.97 Cr
Pharmaceuticals & Biotechnology
10.55%
2
₹508.56 Cr
Pharmaceuticals & Biotechnology
8.38%
3
₹301.05 Cr
Healthcare Services
4.96%
4
₹300.27 Cr
Pharmaceuticals & Biotechnology
4.95%
5
₹295.17 Cr
Healthcare Services
4.87%
6
₹288.66 Cr
Pharmaceuticals & Biotechnology
4.76%
7
₹264.75 Cr
Pharmaceuticals & Biotechnology
4.36%
8
₹249.12 Cr
Pharmaceuticals & Biotechnology
4.11%
9
₹188.32 Cr
Pharmaceuticals & Biotechnology
3.10%
10
₹185.75 Cr
Pharmaceuticals & Biotechnology
3.06%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 SBI Mutual Fund — Portfolio & Holdings
See all funds managed by SBI Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.